Polyneuron Pharmaceuticals Overview
- Year Founded
-
2014

- Status
-
Out of Business
- Employees
-
9

- Latest Deal Type
-
Liquidation
Polyneuron Pharmaceuticals General Information
Description
Developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders safely and effectively.
Contact Information
Website
www.polyneuron.comCorporate Office
- Hochbergerstrasse 60C
- 4057 Basel
- Switzerland
Corporate Office
- Hochbergerstrasse 60C
- 4057 Basel
- Switzerland
Polyneuron Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Bankruptcy: Liquidation | Completed | Bankruptcy: Liquidation | ||||
11. Grant | 14-Apr-2021 | Completed | Generating Revenue | |||
10. Later Stage VC (Series A) | 28-Aug-2020 | Completed | Pre-Clinical Trials | |||
9. Seed Round | 14-May-2018 | Completed | Pre-Clinical Trials | |||
8. Accelerator/Incubator | 18-Sep-2017 | Completed | Pre-Clinical Trials | |||
7. Grant | 31-Aug-2017 | Completed | Pre-Clinical Trials | |||
6. Seed Round | 12-May-2016 | Completed | Pre-Clinical Trials | |||
5. Grant | 05-May-2016 | Completed | Pre-Clinical Trials | |||
4. Accelerator/Incubator | 15-Jul-2015 | $3.35K | $153K | Completed | Startup | |
3. Accelerator/Incubator | 02-Jun-2015 | $150K | $150K | Completed | Pre-Clinical Trials |
Polyneuron Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series Seed |
Polyneuron Pharmaceuticals Comparisons
Industry
Financing
Details
Polyneuron Pharmaceuticals Competitors (40)
One of Polyneuron Pharmaceuticals’s 40 competitors is Toleranzia, a Formerly VC-backed company based in Gothenburg, Sweden.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Toleranzia | Formerly VC-backed | Gothenburg, Sweden | ||||
AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | ||||
Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
Anokion | Venture Capital-Backed | Ecublens, Switzerland |
Polyneuron Pharmaceuticals Patents
Polyneuron Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3056206-A1 | Glycopolymers sequestering carbohydrate-binding proteins | Inactive | 15-Mar-2017 | ||
US-20200079808-A1 | Glycopolymers sequestering carbohydrate-binding proteins | Inactive | 15-Mar-2017 | ||
AU-2018235063-A1 | Glycopolymers sequestering carbohydrate-binding proteins | Inactive | 15-Mar-2017 | ||
EP-3595730-A1 | Glycopolymers sequestering carbohydrate-binding proteins | Inactive | 15-Mar-2017 | C07H15/12 |
Polyneuron Pharmaceuticals Signals
Polyneuron Pharmaceuticals FAQs
-
When was Polyneuron Pharmaceuticals founded?
Polyneuron Pharmaceuticals was founded in 2014.
-
Where is Polyneuron Pharmaceuticals headquartered?
Polyneuron Pharmaceuticals is headquartered in Basel, Switzerland.
-
What is the size of Polyneuron Pharmaceuticals?
Polyneuron Pharmaceuticals has 9 total employees.
-
What industry is Polyneuron Pharmaceuticals in?
Polyneuron Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Polyneuron Pharmaceuticals a private or public company?
Polyneuron Pharmaceuticals is a Private company.
-
What is Polyneuron Pharmaceuticals’s current revenue?
The current revenue for Polyneuron Pharmaceuticals is
. -
How much funding has Polyneuron Pharmaceuticals raised over time?
Polyneuron Pharmaceuticals has raised $46.5M.
-
Who are Polyneuron Pharmaceuticals’s competitors?
Toleranzia, AnTolRx, ImmunOs Therapeutics, Alnylam Pharmaceuticals, and Anokion are some of the 40 competitors of Polyneuron Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »